IP Library Granted Patent US 12,637,713
Granted Patent B2
US 12,637,713 · App. 18/035,073 · Granted May 26, 2026

Methods and systems for phasing sequencing strands and long-range sequencing

Inventors: Omer Barad (Mazkeret Batya, IL); Mark Pratt (Bozeman, MT); Eliane Trepagnier (Oakland, CA); Yoav Etzioni (Tel Aviv, IL); Florian Oberstrass (Redwood City, CA); Gilad Almogy (Palo Alto, CA); Dumitru Brinza (Montara, CA)
Assignee: Ultima Genomics, Inc.
C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,637,713
App. No.
18/035,073
Granted
May 26, 2026
Kind
B2
Abstract

Described herein are methods synchronizing sequencing primers within a sequencing cluster and methods of generating long-range sequencing reads. The methods can include hybridizing primers to polynucleotide copies within a sequencing cluster; extending the primers through a first region of the polynucleotide copies using labeled nucleotides according to a sequencing flow order; extending the primers through a second region of the polynucleotide copies using one or more re-phasing flow steps that each include at least two different types of nucleotide bases; and extending the primers through a third region of the polynucleotide copies using labeled nucleotides according to the sequencing cycle. The rephasing flow steps may be initiated after a predetermined number of sequencing flow steps, after a measured sequencing signal strength falls below a predetermined sequencing signal strength threshold, or a measured sequencing signal-to-noise ratio falls below a sequencing signal-to-noise ratio threshold.

Claims (31)

1 . A method of synchronizing sequencing in a colony, comprising:

(a) providing a sequencing colony comprising a plurality of copies of nucleic acid molecules each having sequence identity to a polynucleotide derived from a sample, wherein each nucleic acid molecule of the plurality of copies comprises a first region, a second region, and a third region;

(b) hybridizing a plurality of primers to the plurality of copies;

(c) extending the plurality of primers through the first region by, in each flow step of a plurality of first flow cycles having a first predetermined number of flow steps, providing a first plurality of nucleotides of a single base type, wherein at least a portion of the first plurality of nucleotides is labeled;

(d) extending, after the first predetermined number of flow steps, the plurality of primers through the second region by, in each flow step of a plurality of second flow cycles, providing a second plurality of nucleotides comprising at least two base types; and

(e) extending the plurality of primers through the third region by, in each flow step of a plurality of third flow cycles, providing a third plurality of nucleotides of a single base type, wherein at least a portion of the third plurality of nucleotides is labeled.

2 . The method of claim 1 , wherein the first predetermined number of flow steps is between about 40 and about 500.

3 . The method of claim 1 , wherein the first predetermined number of flow steps is associated with a predetermined sequencing signal threshold.

4 . The method of claim 1 , wherein the first predetermined number of sequencing flow steps is associated with an expected length of the first region.

5 . The method of claim 1 , wherein the plurality of third flow cycles has a second predetermined number of flow steps, the method further comprising:

(f) extending, after the second predetermined number of flow steps, the plurality of primers through a fourth region of the plurality of copies by, in each flow step of a plurality of fourth flow cycles, providing a fourth plurality of nucleotides comprising at least two base types; and

(g) extending the plurality of primers through a fifth region of the plurality of copies by, in each flow step of a plurality of fifth flow cycles, providing a fifth plurality of nucleotides of a single base type, wherein at least a portion of the fifth plurality of nucleotides is labeled.

6 . The method of claim 5 , wherein the first predetermined number of flow steps and the second predetermined number of flow steps are the same.

7 . The method of claim 1 , wherein a mixture of three different base types is used in at least one flow step of the plurality of second flow cycles.

8 . The method of claim 1 , wherein one or more flow steps of the plurality of second flow cycles comprise 2 to 12 re-phasing flow steps.

9 . The method of claim 1 , wherein one or more flow steps of the plurality of second flow cycles comprise one or more of the following in any order:

(i) a flow step comprising a mixture comprising A, C, and G nucleotides and omitting T nucleotides;

(ii) a flow step comprising a mixture comprising T, C, and G nucleotides and omitting A nucleotides;

(ii) a flow step comprising a mixture comprising T, A, and G nucleotides and omitting C nucleotides; and

(iv) a flow step comprising a mixture comprising T, A, and C nucleotides and omitting G nucleotides.

10 . The method of claim 1 , further comprising sequencing the first region by detecting the presence or absence of an incorporated labeled nucleotide while extending the primers through the first region.

11 . The method of claim 1 , wherein at least a portion of nucleotides provided in the plurality of second flow cycles are unlabeled.

12 . The method of claim 1 , wherein a first flow order of the plurality of first flow cycles and a third flow order of the plurality of third flow cycles are the same.

13 . The method of claim 1 , wherein a first flow order of the plurality of first flow cycles and a third flow order of the plurality of third flow cycles are different.

14 . The method of claim 1 , wherein the plurality of primers is extended through the first region by repeating a first flow order a plurality of times in the plurality of first flow cycles.

15 . The method of claim 14 , wherein the first flow order is repeated 2 times to about 50 times.

16 . The method of claim 1 , wherein a distance between a start of the first region and an end of a final region of the plurality of copies for which sequencing data is generated is at least 300 bases in length.

17 . The method of claim 1 , wherein the sequencing colony is produced by rolling circle amplification of a template nucleic acid molecule, and the sequencing colony comprises multiple copies of the template nucleic acid molecule covalently attached in a linear sequence.

18 . The method of claim 1 , wherein nucleotides provided in the extending (c) comprise a mixture of labeled and unlabeled nucleotides.

19 . The method of claim 1 , wherein nucleotides provided in the extending (d) are non-terminated.

20 . The method of claim 10 , wherein flow steps of the plurality of first flow cycles further comprise (i) detection of a signal from a label of an incorporated labeled nucleotide and (ii) cleavage of the label.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2025
From: BARAD, OMER; PRATT, MARK; TREPAGNIER, ELIANE; ETZIONI, YOAV; OBERSTRASS, FLORIAN; ALMOGY, GILAD; BRINZA, DUMITRU
To: ULTIMA GENOMICS, INC.
Reel/Frame 073984/0171 →
Continuity (2)
Provisional Application 63109822 · Nov 4, 2020
Related Publication 20230407385A1 · Dec 21, 2023
References Cited (111)
US 5714320A · Kool · 1998 [cited by applicant]
US 8364417B2 · Chen · 2013 [cited by applicant]
US 8772473B2 · Huang · 2014 [cited by applicant]
US 9428807B2 · Hubbell · 2016 [cited by applicant]
US 9587274B2 · Chen · 2017 [cited by applicant]
US 9817944B2 · Kural · 2017 [cited by applicant]
US 10192024B2 · Chen · 2019 [cited by applicant]
US 10344328B2 · Barbee · 2019 [cited by applicant]
US 11220709B2 · Oberstrass et al. · 2022 [cited by applicant]
US 11220710B2 · Oberstrass et al. · 2022 [cited by applicant]
US 11459609B2 · Pratt et al. · 2022 [cited by applicant]
US 11462300B2 · Bartov et al. · 2022 [cited by applicant]
US 11578363B2 · Oberstrass et al. · 2023 [cited by applicant]
US 11763915B2 · Etzioni et al. · 2023 [cited by applicant]
US 12209278B2 · Pratt · 2025 [cited by examiner]
US 20090053724A1 · Roth · 2009 [cited by applicant]
US 20100093986A1 · Zwick et al. · 2010 [cited by applicant]
US 20100173303A1 · Ronaghi et al. · 2010 [cited by applicant]
US 20110270533A1 · Zhang · 2011 [cited by applicant]
US 20120252682A1 · Zhou et al. · 2012 [cited by applicant]
US 20130090860A1 · Sikora · 2013 [cited by applicant]
US 20130281306A1 · Rigatti et al. · 2013 [cited by applicant]
US 20140052381A1 · Utiramerur · 2014 [cited by applicant]
US 20140315724A1 · Zhou · 2014 [cited by applicant]
US 20150066824A1 · Harris · 2015 [cited by applicant]
US 20150203910A1 · Smith et al. · 2015 [cited by applicant]
US 20160110499A1 · Donnet · 2016 [cited by applicant]
US 20160326579A1 · Olejnik · 2016 [cited by applicant]
US 20170044601A1 · Crnogorac · 2017 [cited by applicant]
US 20170335387A1 · Brinza · 2017 [cited by applicant]
US 20180330051A1 · Hubbell · 2018 [cited by applicant]
US 20180363047A1 · Smith · 2018 [cited by applicant]
US 20190360034A1 · Zhou et al. · 2019 [cited by applicant]
US 20200199666A1 · Gatti-Lafranconi et al. · 2020 [cited by applicant]
US 20200372971A1 · Etzioni · 2020 [cited by applicant]
US 20200377937A1 · Pratt · 2020 [cited by applicant]
US 20200392584A1 · Almogy · 2020 [cited by applicant]
US 20210010075A1 · Oberstrass · 2021 [cited by applicant]
US 20210054442A1 · Pratt et al. · 2021 [cited by applicant]
US 20210147930A1 · Oberstrass et al. · 2021 [cited by applicant]
US 20210147931A1 · Oberstrass et al. · 2021 [cited by applicant]
US 20210366576A1 · Bartov et al. · 2021 [cited by applicant]
US 20220170089A1 · Pratt et al. · 2022 [cited by applicant]
US 20230060685A1 · Pratt et al. · 2023 [cited by applicant]
US 20230197197A1 · Bartov et al. · 2023 [cited by applicant]
US 20230313289A1 · Oberstrass et al. · 2023 [cited by applicant]
US 20230343416A1 · Etzioni et al. · 2023 [cited by applicant]
US 20240018599A1 · Barad et al. · 2024 [cited by applicant]
US 20240043918A1 · Barad et al. · 2024 [cited by applicant]
US 20240120025A1 · Etzioni et al. · 2024 [cited by applicant]
US 20240287483A1 · Mazur et al. · 2024 [cited by applicant]
US 20240309445A1 · Oberstrass et al. · 2024 [cited by applicant]
US 20250197928A1 · Pratt et al. · 2025 [cited by applicant]
KR 20180055905A · 2018 [cited by applicant]
WO 9844152A1 · 1998 [cited by applicant]
WO 199844151A1 · 1998 [cited by applicant]
WO 2012134602A2 · 2012 [cited by applicant]
WO 2012166742A2 · 2012 [cited by applicant]
WO 2012166742A3 · 2013 [cited by applicant]
WO 2012134602A3 · 2013 [cited by applicant]
WO 2017062863A1 · 2017 [cited by applicant]
WO 2019084158A1 · 2019 [cited by applicant]
WO 2019099886A1 · 2019 [cited by applicant]
WO 2019191003A1 · 2019 [cited by applicant]
WO 2020172197A1 · 2020 [cited by applicant]
WO 2020185790A1 · 2020 [cited by applicant]
WO 2020186243A1 · 2020 [cited by applicant]
WO 2020227137A1 · 2020 [cited by applicant]
WO 2020227143A1 · 2020 [cited by applicant]
WO 2020236630A1 · 2020 [cited by applicant]
WO 2020240025A1 · 2020 [cited by applicant]
WO 2021007495A1 · 2021 [cited by applicant]
WO 2022051296A1 · 2022 [cited by applicant]
WO 2022056296A1 · 2022 [cited by applicant]
WO 2022099271A1 · 2022 [cited by applicant]
WO 2022109574A1 · 2022 [cited by applicant]
WO 2022204685A1 · 2022 [cited by applicant]
WO 2023004421A1 · 2023 [cited by applicant]
WO 2023288319A1 · 2023 [cited by applicant]
WO 2023010069A1 · 2023 [cited by applicant]
WO 2023010131A1 · 2023 [cited by applicant]
WO 2023060091A1 · 2023 [cited by applicant]
WO 2023081653A1 · 2023 [cited by applicant]
WO 2023081883A2 · 2023 [cited by applicant]
WO 2023081883A3 · 2023 [cited by applicant]
WO 2023141430A1 · 2023 [cited by applicant]
WO 2023164505A2 · 2023 [cited by applicant]
WO 2023164505A3 · 2023 [cited by applicant]
WO 2024102889A1 · 2024 [cited by applicant]
Ali, M.M. et al. (2014). “Rolling Circle Amplification: A Versatile Tool For Chemical Biology, Materials Science and Medicine,” Chem. Soc. Rev. 43:3324, 19 pages. [cited by applicant]
Chaisson, M.J. et al. (2009). “De Novo Fragment Assembly With Short Mate Paired Reads: Does The Read Length Matter?,” Genome Research 19:336-346. [cited by applicant]
Dean et al. (2001). “Rapid Amplification Of Plasmid And Phage DNA Using Phi29 DNA Polymerase And Multiply-Primed Rolling Circle Amplification,” Genome Research 11:1095-1099. [cited by applicant]
Depristo, M.A. et al. (May 2011, e-pub. Nov. 1, 2011). “A Framework For Variation Discovery And Genotyping Using Next-Generation DNA Sequencing Data,” Nature Genetics 43(5):491-498, 20 pages. [cited by applicant]
Hwang, S. et al. (Dec. 7, 2015). “Systematic Comparison Of Variant Calling Pipelines Using Gold Standard Personal Exome Variants,” Sci Rep. 5(17875):1-8. [cited by applicant]
International Preliminary Report on Patentability, issued May 8, 2023, for PCT Application No. PCT/US2021/072218, filed Nov. 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion, mailed Mar. 2, 2022, for PCT Application No. PCT/US2021/072218, filed Nov. 3, 2021, 13 pages. [cited by applicant]
Mielczarek, M. et al. (2016). “Review Of Alignment And SNP Calling Algorithms For Next-Generation Sequencing Data,” J. Appl. Genetics 57:71-79. [cited by applicant]
Miller, J.R. et al. (2010, e-pub. Mar. 6, 2010). “Assembly Algorithms For Next-Generation Sequencing Data,” Genomics 95:315-327. [cited by applicant]
Mitra, R.B. et al. (2003). “Fluorescent in Situ Sequencing on Polymerase Colonies,” Analytical Biochemistry 320:55-65. [cited by applicant]
Nielsen, R. et al. (Jun. 2011). “Genotype And SNP Calling From Next-Generation Sequencing Data,” Nature Reviews Genetics 12(6):443-451, 20 pages. [cited by applicant]
Partial Supplementary European Search Report, dated Jul. 7, 2023, for European Patent Application No. 20801590.9, 19 pages. [cited by applicant]
Peng, Q. et al. (2019, e-pub. Mar. 18, 2019). “Targeted Single Primer Enrichment Sequencing with Single End Duplex-UMI,” Scientific Reports 9(4810):1-10. [cited by applicant]
Poplin, R. et al. (Jul. 24, 2018, e-pub. Nov. 14, 2017). “Scaling Accurate Genetic Variant Discovery To Tens Of Thousands Of Samples,” BioRxiv, located at a https://www.biorxiv.org/content/biorxiv/early/2017/11/14/20117… [cited by applicant]
Somervuo, P. et al. (2018). “BARCOSEL: A Tool for Selecting an Optimal Barcode Set for High-Throughput Sequencing,” BMC Bioinformatics 19:257, 6 pages. [cited by applicant]
U.S. Appl. No. 18/035,075, filed May 2, 2023, by Omer, et al. (A copy of the U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004). [cited by applicant]
U.S. Appl. No. 18/035,081, filed May 2, 2023, by Omer, et al. (A copy of the U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004). [cited by applicant]
U.S. Appl. No. 18/281,930, filed Sep. 13, 2023, by Oberstrass et al. (A copy of the U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21… [cited by applicant]
U.S. Appl. No. 18/362,754, filed Jul. 31, 2023, by Yoav, et al. (A copy of the U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 200… [cited by applicant]
Van Dijk, E.L. et al. (2018). “The Third Revolution in Sequencing Technology,” Trends in Genetics 34(9):666-681. [cited by applicant]
Zerbino, D.R. et al. (2008, e-pub. Mar. 18, 2008). “Velvet: Algorithms For De Novo Short Read Assembly Using De Bruijn Graphs,” Genome Research 18:821-829, 11 pages. [cited by applicant]
Zook, J. M. et al. (Apr. 1, 2019). “An Open Resource For Accurately Benchmarking Small Variant And Reference Calls,” Nature Biotechnology 37:561-566, 14 pages. [cited by applicant]